These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37137903)

  • 21. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
    Asarnow D; Wang B; Lee WH; Hu Y; Huang CW; Faust B; Ng PML; Ngoh EZX; Bohn M; Bulkley D; Pizzorno A; Ary B; Tan HC; Lee CY; Minhat RA; Terrier O; Soh MK; Teo FJ; Yeap YYC; Seah SGK; Chan CEZ; Connelly E; Young NJ; Maurer-Stroh S; Renia L; Hanson BJ; Rosa-Calatrava M; Manglik A; Cheng Y; Craik CS; Wang CI
    Cell; 2021 Jun; 184(12):3192-3204.e16. PubMed ID: 33974910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2.
    Prévost J; Richard J; Gasser R; Ding S; Fage C; Anand SP; Adam D; Gupta Vergara N; Tauzin A; Benlarbi M; Gong SY; Goyette G; Privé A; Moreira S; Charest H; Roger M; Mothes W; Pazgier M; Brochiero E; Boivin G; Abrams CF; Schön A; Finzi A
    J Biol Chem; 2021 Oct; 297(4):101151. PubMed ID: 34478710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
    Anand SP; Chen Y; Prévost J; Gasser R; Beaudoin-Bussières G; Abrams CF; Pazgier M; Finzi A
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33003587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
    Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD
    Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody.
    Lee M; Major M; Hong H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
    Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
    Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
    Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
    Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike.
    Díaz-Salinas MA; Li Q; Ejemel M; Yurkovetskiy L; Luban J; Shen K; Wang Y; Munro JB
    Elife; 2022 Mar; 11():. PubMed ID: 35323111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.
    Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O
    Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike.
    Wrobel AG
    Curr Opin Struct Biol; 2023 Aug; 81():102619. PubMed ID: 37285618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All-atom simulations of the trimeric spike protein of SARS-CoV-2 in aqueous medium: Nature of interactions, conformational stability and free energy diagrams for conformational transition of the protein.
    Panthi B; Dutta S; Chandra A
    J Comput Chem; 2023 Jun; 44(17):1560-1577. PubMed ID: 37000187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.